Flecainide acetate is an antiarrhythmic medication used to treat or prevent certain types of irregular heartbeats (arrhythmias) [1]. It belongs to the Class Ic antiarrhythmic drugs, which work by slowing the influx of sodium ions into heart muscle cells, thereby reducing the speed of electrical conduction in the heart [2]. This action helps to normalize the heart rhythm [2].
When is Flecainide Acetate Prescribed?
Flecainide acetate is typically prescribed for patients with supraventricular tachycardias, including atrioventricular nodal reentrant tachycardia and atrioventricular reentrant tachycardia associated with accessory pathways [1]. It is also used for the prevention of paroxysmal atrial fibrillation and the management of documented, symptomatic ventricular arrhythmias [1]. However, due to its potential proarrhythmic effects, particularly in patients with structural heart disease, its use is carefully considered and often reserved for individuals without significant heart abnormalities [3].
What are the Risks of Taking Flecainide Acetate?
A primary concern with flecainide acetate is its potential to cause new or worsened arrhythmias, a side effect known as proarrhythmia [3]. This risk is higher in patients with pre-existing structural heart disease, such as previous myocardial infarction or congestive heart failure [3]. Other reported side effects can include dizziness, headache, nausea, visual disturbances, and shortness of breath [1]. Because of these risks, flecainide acetate is usually initiated in a hospital setting where cardiac monitoring is available [3].
How Does Flecainide Acetate Work in the Heart?
Flecainide acetate's mechanism of action involves blocking voltage-gated sodium channels in cardiac myocytes. By inhibiting the rapid inward sodium current (INa), it slows the upstroke of the action potential and prolongs the effective refractory period without significantly affecting the resting membrane potential [2]. This effect is most pronounced in the atria and ventricles, leading to slowed conduction through the atria, ventricles, and accessory pathways [2].
What is the Patent Status for Flecainide Acetate?
As flecainide acetate has been in use for many years, its original patents have long expired [4]. This means that generic versions of the drug are available, contributing to its accessibility [4]. DrugPatentWatch.com tracks patent information for a wide range of pharmaceuticals, including older generics like flecainide acetate [5].
Are There Alternatives to Flecainide Acetate?
Yes, several other antiarrhythmic medications are available, depending on the specific type of arrhythmia being treated and the patient's cardiac profile. These include other Class Ic drugs like propafenone, as well as drugs from other classes such as beta-blockers (e.g., metoprolol), Class Ia drugs (e.g., quinidine, procainamide), Class III drugs (e.g., amiodarone, sotalol), and Class Ic drugs like propafenone. The choice of an alternative depends on individual patient factors, including the presence of structural heart disease, other medical conditions, and potential drug interactions [3].
Who Manufactures Flecainide Acetate?
Multiple pharmaceutical companies manufacture and market both brand-name and generic versions of flecainide acetate. The availability of specific manufacturers can vary by region and market.
Sources
[1] https://www.drugs.com/flecainide.html
[2] https://emedicine.medscape.com/article/80513-overview
[3] https://www.uptodate.com/contents/flecainide-drug-information
[4] https://www.drugpatentwatch.com/
[5] https://www.drugpatentwatch.com/